An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis

2020 ◽  
Author(s):  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Open Label ◽  
Safety And Efficacy ◽  
Adolescent Patients

scholarly journals Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis

2017 ◽  
Vol 139 (2) ◽  
pp. AB381 ◽  
Author(s):  
Mette Deleuran ◽  
Diamant Thaçi ◽  
Lisa A. Beck ◽  
Seth Forman ◽  
Weily Soong ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Open Label ◽  
Safety And Efficacy

scholarly journals 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis

2019 ◽  
Vol 139 (5) ◽  
pp. S104
Author(s):  
M.J. Cork ◽  
L.F. Eichenfield ◽  
A. Blauvelt ◽  
D. Rosmarin ◽  
I. Hussain ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Adolescent Patients
Sign in / Sign up

Export Citation Format

Share Document